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INVITED REVIEW
Summary: Symposium on Signal Transduction
Editor's Note:
The International Society of Nephrology is currently sponsoring a series entitled "Forefronts in Nephrology," under the direction of Professor
G. Giebisch. On October 9—12, 1988, a Symposium on Signal Transduction was held at the Chatham Bars Inn (Chatham, Massachusetts, USA),
and was chaired by Dr. D. A. Ausiello (Boston, Massachusetts). The following is a summary of ihe Symposium, prepared by Dr. Ausiello.
The second Forefronts in Nephrology Symposium was held
on October 9—12, 1988 on the topic of signal transduction. Over
100 participants came to the Chatham Bars Inn on Cape Cod,
Massachusetts to hear 20 speakers discuss state-of-the-art
concepts in cellular signalling. Two key note addresses on the
first and second days by H. Gobind Khorana, Nobel Laureate
from the Massachusetts Institute of Technology on the "Stnic-
ture and Function of Rhodopsin" and Henry R. Bourne of the
University of California, San Francisco on the "Molecular
Biology of Guanine Nucleotide Regulatory (G) Proteins" set
the ground-work for the most fundamental understanding of
receptor linked processes described to date. New information
on receptor-G protein-effector interactions were obtained by
utilizing techniques of site-specific mutagenesis and the forma-
tion of chimeric G-proteins with multiple functions. Dr. Kho-
rana emphasized the structure-function relationship between
the amino acid sequence of rhodopsin and its ability to serve as
the receptor for initiating the visual response. Dr. Bourne
emphasized the multiplicity of structure-function relationships
built into the guanine nucleotide regulatory proteins which
include specific conformation for receptor coupling, for binding
of guanine nucleotides, and for coupling to effectors including
adenylyl cyclase, phospholipases, and possibly ion channels.
A significant portion of the symposium was dedicated to the
signal transduction pathways involved in phospholipid metab-
olism and intracellular calcium pathways. Dr. Exton of Vander-
bilt University School of Medicine reviewed the general scheme
of hormonal stimuli activating a specific phospholipase C for
PIP2 which leads to the generation of IP3 and DAG, and to the
release of intracellular Ca2 and activation of protein kinase C.
Dr. Exton noted that while this overall scheme remains valid,
the actual regulation of the rise in intracellular Ca2 and DAG
may be more complex in several cell systems. For example, in
hepatocytes vasopressin at 10 M stimulates an increase in
intracellular Ca2 and Ca2 influx when Ca2 is present in the
extracellular milieu. In the absence of extracellular Ca2, a
concentration of vasopressin of i09 M is needed to increase
intracellular 1P3 and Ca2t Hence, the possibility has to be
considered that at low vasopressin concentrations the initial
rise in intracellular Ca2 may represent not only release from
intracellular stores but also Ca2 influx. It is possible that this
influx is also regulated by phospholipase C which, in turn, may
be modulated by G proteins. Furthermore, the time course of
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PIP2 breakdown, which occurs within seconds, and the build-up
of DAG, which occurs progressively over minutes, are not
compatible with the simple scheme that 1P3 and DAG both
derive from PIP2 breakdown. Most likely, the majority of the
DAG generated derives from phosphatidylcholine, and it is
catalyzed by different GTP-dependent phospholipase Cs for
phosphatidylcholine. Thus, protein kinase C may be regulated
by DAG which is generated by the action of a phospholipase C
on phosphatidylcholine. In addition, there may be a phospho-
lipase D which could generate phosphatidic acid from sub-
strates such as phosphatidylcholine. The roles of such a phos-
pholipase D and the resulting phosphatidic acid remain to be
defined.
Dr. Joseph V. Bonventre of the Massachusetts General
Hospital discussed the role of Ca2 and phospholipases in renal
cell signal transduction. Since phospholipase A2 is believed to
be rate limiting for prostaglandin synthesis, the regulation of
this enzyme in the renal mesangial cell is of importance for both
physiology as well as pathophysiological processes. It was
found that PLA2 activity was modulated over the physiological
range of Ca2 concentrations. Protein kinase C activation
enhanced prostaglandin production and phospholipase activity
if the cytosolic calcium concentration was simultaneously in-
creased to levels found after hormonal stimulation with, for
example, vasopressin. A number of studies demonstrated that
the regulation of phospholipase A2 is multifaceted. The follow-
ing conclusions could be reached: 1) PLA2 activity is modulated
over the physiological range of Ca2 concentrations observed
in mesangial cells; 2) protein kinase C modulates the Ca2-
dependent modulation of PLA2; 3) protein kinase C activation
results in a stable modification or an increase in the concentra-
tion of active enzyme which can be partially purified from the
soluble fraction when cells are homogenized with Ca2 chela-
tors; 4) PLA2 may move on or off the membrane in a Ca2-
dependent fashion; 5) PLA2 can be activated in a pertussis
toxin-insensitive manner by epidermal growth factor, which
does not increase phospholipase C activity or cytosolic Ca2
concentrations in the inesangial cells, suggesting an additional
mechanism of regulation; and 6) in addition to the widely
studied roles in inflammation and vascular physiology, products
of the activation of PLA2 may also be important to the regula-
tion of growth. Dr. Schlondorff, a discussant of these sections,
raised the possibility that G proteins are involved in signal
transduction in cultured mesangial cells in response to the
hormone angiotensin II. Angiotensin II appears to stimulate
both phospholipases C and A2. PIP2-specific phospholipase C
can be activated by GTP analogs and inhibited by pertussis
toxin. At least one known type of G protein, G-2, has been
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found in mesangial cells by immunoblotting and Northern blot
analysis. Dr. Schlondorff proposed that in mesangial cells,
angiotensin II stimulation of phospholipase C involves a spe-
cific G protein. Furthermore, the activation of phospholipase
A2 may be influenced by phospholipase C-dependent events.
Subsequent discussions led to a detailed analysis of phos-
phatidylinositol metabolism and its regulation by hormones in
renal epithelia. Dr. Phil W. Majerus of Washington University
School of Medicine pointed out the paradox that while the four
enzymatic forms of phospholipase C which have been cloned
are functionally quite similar, they have very limited sequence
homology. He also made the provocative point that in most
cells the amount of inositol 1,3,4 phosphate greatly exceeds that
of the 1,4,5 isoform, suggesting that the inositol tetrakisphos-
phate, which is the precursor of the 1,3,4 isoform, may have an
important biological function. He also discussed the cyclic
forms of inositol phosphate and reviewed the evidence that
cyclic 1P3 has signal transduction actions, such as in the case of
Limulus where photoreceptors will increase potential difference
with no change in cytosolic Ca2 in response to these com-
pounds. Finally, Dr. Majerus questioned whether U proteins
actually activate phospholipase C and suggested the alternative
possibility that the U proteins, when stimulated, release a tonic
inhibition of the enzyme. Dr. Keith Hruska of Washington
University School of Medicine described his work on opossum
kidney cells where he has shown that parathyroid hormone
increases cytosolic Ca2 and the release of 1P3. Surprisingly,
forskolin and cAMP, which do not affect 1P3, also caused an
increase of cytosolic Ca2 and augmented the prolonged phase
of Ca2 elevation after parathyroid hormone. Dr. Hruska raised
the intriguing possibility that hormones had dual signalling
mechanisms with quantitative as well as qualitative regulation
of intracellular signals.
Dr. Lutz Birnbaumer of Baylor College of Medicine reviewed
the biology of guanine nucleotide regulatory proteins as it
relates to the regulation of ion channels. Dr. Birnbaumer
pointed out that the concept of second messengers has been a
common notion for a number of years, but it has become clear
recently that, between the extracellular hormonal agent (the
first messenger) and the production of the intracellular modu-
latory agent (the second messenger), there is an additional
modulatory step—the activation of C proteins, the theme first
introduced earlier in this symposium by Drs. Khorana and
Bourne. The G proteins are heterotrimeric proteins consisting
of a, /3, and y subunits. Generally, variation in their subunit
structure determines the character of the U proteins, particu-
larly variation in the nature of the a subunit. There are now
many different U proteins described—some with known func-
tions and others with functions yet to be defined. Typically, U
proteins are present in an inactive GDP-bound form in close
association with membrane receptors and effectors. Activation
of the receptors promotes GDP loss and GTP binding to the a
subunit of the U proteins with separation of the subunits. In
most cases the active a subunit activates the effector molecule.
One specific target for G proteins is adenylyl cyclase which in
turn produces cAMP. Indeed, it has been this model that has
served as the paradigm for G protein action. More recently,
however, some U proteins, particularly those that are pertussis
toxin-sensitive, have been shown to modulate membrane ion
channels directly and alter the probability that they will trans-
port ions. One such channel is the muscarinic-activated K
channel of atrial cardiac myocytes. The activation of such U
protein-controlled ion channels can be studied by applying U
protein subunits to channels in isolated membrane patches
using patch clamp methodology. Dr. Birnbaumer demonstrated
that the source of the subunits can either be native tissue or
recombinant proteins expressed from the cloned genes of
specific subunits. This work has opened up a new realm for ion
channel regulation and raises the possibility that, in epithelial
cells, U proteins may play unique roles at topographically
distinct locations at the basolateral membrane and at the apical
membrane. Drs. Ausiello and Stanton produced data demon-
strating that, in apical membranes of epithelial cells, cation-
selective channels in the inner medullary collecting duct (Dr.
Stanton) or sodium-selective channels in the apical membrane
of A6 cells (Dr. Ausiello) can be gated by a subunits of pertussis
toxin-sensitive U proteins. This raises the possibility that signal
transducing proteins and possibly receptors are localized in
apical membranes where they are capable of modulating chan-
nels. How these U proteins work in relationship to other
intracellular and extracellular signalling processes known to
alter ionic movement across epithelia remains to be defined.
Dr. Rainer Ureger of the Albert-Ludwigs Universitat in West
Germany presented evidence that other intracellular modula-
tors in addition to U proteins are also important in epithelia for
the regulation of ion channels. For chloride channels, of which
there are many types in epithelial tissues, important regulatory
mechanisms appear to be the phosphorylation potential of the
cell, especially as mediated by protein kinase A, and levels of
intracellular Ca2. Increases in either of these appear to in-
crease the probability that chloride channels remain open and
therefore conduct chloride. K channels appear to be regulated
by the same factors as chloride channels but in epithelial
tissues, in particular, they also appear to be strongly regulated
by intracellular pH. In contrast to Ca2 and phosphorylation,
increasing the W ion concentration dramatically reduces the
probability that at least one type of K channel will conduct
potassium. The same channels are also inhibited by high
concentrations of intracellular ATP whose effect can be com-
petitively blocked by intracellular ADP. Thus, this type of K
channel is suited to monitor the metabolic state of epithelial
tissues.
The linkage between two important aspects of signal trans-
duction, that is, ion transport and cell growth, was discussed in
sessions dealing with the Na/H exchanger. Dr. Jacques
Pouyssegur of the Université de Nice reviewed the work of his
group on the structure and function of the Na/H antiporter.
This group has cloned a transport protein from human genomic
DNA which was expressed in mutant mouse cells that lacked
Na/H exchange activity. The open reading frame includes
894 amino acids with an estimated molecular weight of 100,000
kD, although there are several potential glycosylation sites. The
cDNA has been inserted into the pMAMneo vector and ex-
pressed in mouse L cells with impressive modulation by dex-
amethasone via the MMTV promoter. Dr. Peter S. Aronson
(Yale University) discussed the kinetic and functional charac-
terization of the Na/H antiporter and reported preliminary
evidence concerning the partial purification of membrane pro-
teins from renal brush-border vesicles using amiloride affinity
chromatography. This approach appears promising but confir-
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mation of protein sequence similarity with that predicted from
cDNA clones was viewed as an important criterion for selection
since the amiloride affinity is fairly low. Dr. Aronson also raised
the possibility that in renal epithelia there may be more than one
type of Na/H exchanger, a possible "house-keeping" NaI
H exchanger, and a more distinct form necessary for trans-
epithelial Na transport located on apical membranes.
Several sessions were dedicated to the understanding of the
regulation of growth as it might apply to renal cell development.
Dr. Gordon N. Gill of the University of California, San Diego
defined the molecular biology of epidermal growth factor (EGF)
as a 170 kD protein containing intrinsic tyrosine kinase activity.
The 1186 amino acid protein consists of four domains: an
extracellular ligand binding domain, a hydrophobic transmem-
brane domain, a protein tyrosine kinase domain of highly
conserved structure with other members of the extended pro-
tein tyrosine kinase gene family, and a carboxyl terminal
regulatory domain. Site-directed mutations placed in the EGF
receptor cDNA, which is then expressed in null recipient cells,
provided the following information: a) The intrinsic protein
tyrosine kinase activity is essential for biological responses to
EGF, including increases in cytosolic calcium, gene expression
and cell proliferation. b) The transmembrane domain is tolerant
of several changes which in other receptors result in constitu-
tive activation. However, the mutant EGF receptors containing
these changes remain ligand-dependent for their activity. c) The
carboxyl terminus is a region of seif-phosphorylation which
functions as an inhibitor and alternate substrate serving to
regulate the activity of the intrinsic protein tyrosine kinase.
Deletional analysis of the carboxyl terminus indicates that its
removal enhances ligand-dependent protein tyrosine kinase
activity. The increase exceeds that seen with the holoreceptor,
probably due to the stronger effects of deletion preventing
reversibility which occurs through the action of tyrosine phos-
phatases and reversal of the kinase reaction. Expression of the
cytoplasmic domain in the baculovirus expression system indi-
cates that the kinase domain's activity can be stimulated by
sphingosine and ammonium sulfate. This growth factor receptor
is thus strictly ligand-dependent and subject to regulatory
controls which limit its activity normally to environmentally
signaled conditions. Removal of inhibitory constraints creates a
transforming oncoprotein.
Dr. Karl S. Skorecki of the University of Toronto turned the
discussion to signalling mechanisms involved in some of the
non-mitogenic actions of growth factors, in particular EGF in
the kidney. Dr. Skorecki reviewed the effect of EGF on both
glomerular filtration as well as tubular reabsorptive function.
The glomerular mesangial cell appears to be an important target
for both the mitogenic and non-mitogenic action of a number of
different growth factors. Using the rat glomerular mesangial cell
in culture as a model system, Skorecki and colleagues reported
that the full extent of vasoactive-hormone-stimulated prosta-
glandin production requires the participation of growth factors,
with EGF serving as a prototype. In this regard, the experimen-
tal system served as an ideal model for examining the differen-
tial regulation of phospholipase C and phospholipase A2 in a cell
type with a normal complement of EGF receptors. Studies
using multiple phospholipid labelling strategies and measure-
ment of second messenger generation have suggested a mech-
anism for the regulation of hormone-stimulated arachidonic
acid release involving sequential activation of phospholipases.
According to this formulation, vasoactive hormones such as
vasopressin, angiotensin II, and endothelin, operate through a
pertussis toxin-insensitive GTP-binding protein to activate
phospholipase C. The consequent release of inositol tris-phos-
phate and rise in cytosolic Ca2 are necessary and sufficient for
the activation of phospholipase A2 and the resultant eicosanoid
production. In contrast, activation of phospholipase C does not
serve as a prominent source for the release of arachidonic acid
in response to stimulatory ligands. Rather, the full extent of
phospholipase A2 activation and eicosanoid production appears
to require the additional participation of protein kinase C-
mediated and tyrosine-mediated phosphorylation reactions. It
is the combination of the dual signals (inositol tris-phosphate!
calcium along with diacylglycerol/protein kinase C) of the
bifurcating phospholipase C pathway that reconstitutes the full
arachidonic acid releasing action of vasopressin and other
vasoactive hormones. The additional contribution of a tyrosine-
kinase family of growth factors additionally contributes to the
extent of arachidonate release. In the case of the mesangial cell,
EGF causes a synergistic activation of phospholipase A2 inde-
pendent of any effect of EGF on phospholipase C. As in the
case of protein kinase C, it is not clear as yet whether
phospholipase A2 itself is a substrate for tyrosine phosphoryla-
tion or whether a closely-related modulatory protein is in-
volved.
Dr. Lewis T. Williams from the University of California, San
Francisco discussed the molecular and cell biology of platelet-
derived growth factor (PDGF). He emphasized that this growth
factor is synthesized and released from a number of non-platelet
sources including endothelial cells, mesangial cells, activated
macrophages, cytotrophoblasts, and smooth muscle cells. The
biologically active factor is a homodimeric or heterodimeric
protein of two distinct gene products encoding PDGF A and B
chains. All three forms of PDGF (AA, BB, AB) activate the
PDGF receptor form that Dr. Williams and colleagues purified
and for which they obtained encoding cDNA. This was con-
firmed by ligand-induced tyrosine phosphorylation of the recep-
tor and other cellular substrates, receptor internalization, acti-
vation of inositol phosphate production, transient elevation of
intracellular [Ca2], and increase in DNA synthesis. Each of
these assays has been used to evaluate the contribution of
specific PDGF receptor domains to ligand-activated responses
in mutated, expressed receptors. Substitution of the putative
ATP binding lysine with alanine abolishes PDGF receptor
tyrosine kinase activity and ablates all coupled responses,
except PDGF receptor internalization. Similar interruption, of
PDGF receptor responses to ligand binding were also identified
in stable transfectant CHO cells expressing mutated PDGF
receptors that lack the C-terminal 99 amino acids, or have
transmembrane domain substitutions with the transmembrane
regions of either c-neu or the transforming neu oncogene.
Deletion of the PDGF receptor interkinase domain (interrupting
the tyrosine kinase region) blocked PDGF-induced DNA syn-
thesis without affecting other PDGF cellular responses. This
region is also apparently required for PDGF receptor associa-
tion with phosphatidylinositol kinase which follows PDGF
binding. The activation of receptor tyrosine kinase-mediated,
self-phosphorylation effects changes in PDGF receptor confor-
mation that are reflected by availability of a cytoplasmic domain
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for domain specific antibody binding. Such conformational
changes may be important in receptor association with effector
proteins such as phosphatidylinositol kinase.
Dr. Michael F. Horster from the University of Munich then
related some of the molecular events described at this meeting
to functional data involving the mechanisms of kidney cell
growth and differentiation. Dr. Horster reported the variety of
transport mechanisms that are differentially expressed during
the development of cultured renal tubular cells including the
important observation that aldosterone induces chloride trans-
port in cultured rabbit cortical collecting tubule cells. Although
the mechanisms of action of the hormones remain to be defined,
Dr. Horster's data suggest that steroid induced genes may play
a key role in the process of epithelial cell differentiation.
Dr. Richard Klausner of the National Institutes of Health and
Dr. Eric Neilson of the University of Pennsylvania discussed
the importance of T cell receptors and T cell function in the
kidney. Dr. Klausner reviewed the molecular structure of the T
cell receptor as a model for ligand-induced signal transduction.
The T cell receptor is comprised of 5-7 polypeptide chains in
non-covalent association. Two of the chains, a and /3, are
rearranged for ligand recognition in the context of MHC. They
form an association with 6, e, v , chains in order to form a
collectively functioning unit modulating cytosolic activity in the
T cell. Following ligand binding on normal cells, the y chain is
phosphorylated on serine residues and the chain on tyrosine
residues. This phosphorylation process is the first link in a
series of biochemical events important to growth and differen-
tiation within the T cell repertoire. Cell lines derived from
normal or genetically disturbed animals and humans demon-
strate variability in the phosphorylation process. Such mutants
offer the opportunity to examine the interactive role of the cell
surface T cell receptor with its internal milieu.
Dr. Eric Neilson reviewed the immunologic mechanisms
which determine susceptibility to interstitial nephritis. These
determinants of susceptibility include expression of the kidney
target antigen, the abrogation of immunologic tolerance, the
presence of immune-response genes regulating contrasuppres-
sion, and the visibility of parenchymal MHC antigens. While
signal transduction events may be important in each of these
parameters of susceptibility, the issues of signal transduction
have been most clearly demonstrated by the process of target
antigen modulation of MHC at the kidney cell level. In anti-
tubular basement membrane disease anti-tubular basement
membrane antibodies bind to the proximal tubular cell express-
ing the 3M-i target antigen. This binding specifically decreases
class II MHC antigens by a reduction in transcription. Cell
surface class II expression is reduced, perhaps as a protective
response, depriving the cell of further recognition by roaming
nephritogenic lymphocytes. Control of MHC visibility by target
ligand interactions with the immune system clearly represents
an important new area in which to pursue the biochemical
process of signal transduction.
Finally, two speakers, Dr. Thomas Stossel of the Massachu-
setts General Hospital and Dr. Jeffrey I. Kreisberg of the
University of Texas Health Science Center at San Antonio,
turned the discussion to intracellular processes involving cyto-
skeletal organization and stimulus-motility transduction. Dr.
Stossel reviewed stimulus-motility transduction in macro-
phages and how cytoplasmic actin assembly is regulated by the
interaction of a variety of actin-binding proteins with specific
functions. The association with actin of two important regula-
tory proteins, gelsolin (which severs actin filaments) and pro-
film (which binds to actin monomers and prevents assembly
into filaments) is now known to be regulated by phosphatidyl-
inositol bisphosphate (PIP2), providing a direct link between
signal transduction events at the cell membrane, and cytoskel-
etal modulation. The PIP2-induced dissociation of gelsolin and
profilin from actin occurs at the cell membrane, and recent data
have shown that both of these molecules migrate to the periph-
ery of the cell during activation of blood platelets.
Using cultured kidney mesangial cells, Dr. Kreisberg showed
that cAMP elevation activates urokinase plasminogen activator
which results in myosin light chain dephosphorylation, stress
fiber disassembly, cell shape changes, and adhesion loss. These
changes, stimulated by vasoactive mediators, illustrate the
potential physiological importance of signal transduction events
in controlling cell shape and function.
In summary, the second Forefronts in Nephrology Sympo-
sium provided a comprehensive view of the complex interac-
tions and cross-talk among many transducing systems, several
of which were previously felt to be distinct and unrelated to
cellular signalling. The view is now rapidly emerging that
interactive play among classical receptors, modulatory pro-
teins, second messengers, and phospholipid metabolites must
be considered in light of their roles in the modulation of ion
transport, cytoskeletal organization, and growth and differenti-
ation. With the rapidly emerging understanding of many of the
effector systems at the molecular level through the tools of
molecular biology, these complex interactions are gradually
being unraveled.
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